PSPascal Steenvoorde

Pascal Steenvoorde

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pascal Steenvoorde has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 August 2006
      • Vol. 72  (4) , 404-10

    Development of a clinical decision tool for suspected scaphoid fractures.

    by Pascal Steenvoorde, Cathrien Jacobi, Alex Van Der Lecq, Louk Van Doorn, Job Kievit, Jacques Oskam

    Scaphoid fractures are the most common carpal fractures; their overall incidence is however low. Missing a scaphoid fracture may lead to a non-union with a possible disastrous outcome for the patient; for this reason, treatment of a suspected scaphoid fracture, even without a proven fracture on the first radiograph, has been conservative with plaster treatment. There are many clinical tests developed to diagnose a scaphoid fracture. However not all tests are equally practical, and their sensitivity and specificity are not always known, or are very low. In this study 18 clinical tests were evaluated and a subset of 7 tests remained, which were found to be practical and/or had a high enough sensitivity. A clinical decision protocol was developed using a combination of these seven tests, in order to improve diagnostic accuracy and at the same time reduce unnecessary plaster cast treatment of patients with a suspected scaphoid, who turn out to only have a sprained wrist.


    • 10 June 2006
      • Vol. 150  (23) , 1291

    [Diagnostic image (277). A woman with epigastric pain 10 years after a mastectomy].

    by P Steenvoorde, A G Menon

    A 59-year-old woman presented with epigastric pain due to peritonitis carcinomatosa caused by breast cancer diagnosed and surgically treated 10 years earlier.

    • 1 January 2006
      • Vol. 52  (1) , 52-4

    Negative pressure wound therapy to treat peri-prosthetic methicillin-resistant Staphylococcus aureus infection after incisional herniorrhaphy. A case study and literature review.

    by Pascal Steenvoorde, Ronald A De Roo, Jaques Oskam, Peter Neijenhuis

    The preferred treatment for incisional hernias occurring post laparotomy involves use of prosthetic mesh. If this mesh becomes infected, it may have to be removed to achieve wound healing. A patient with a methicillin-resistant Staphylococcus aureus-infected prosthetic mesh received negative pressure wound therapy to help facilitate healing without removing the prosthetic mesh applied to manage his hernia. After almost 4 weeks of treatment, the wound was closed secondarily. The literature contains many case studies about the use of NPWT for a variety of wounds but information about its safety and effectiveness for managing methicillin-resistant Staphylococcus aureus-infected prosthetic mesh is limited. The results of this case study add to the evidence that controlled clinical studies are warranted.


  • Giant Colonic Diverticula

    by P. Steenvoorde, F.J. Vogelaar, J. Oskam, R.A.E.M. Tollenaar

    Background: A rare complication of diverticulosis of the colon is giant colonic diverticula (GCD). The condition was first described in English literature in 1953 [1, 2]. Methods: A Medline search was undertaken for English, French and German language articles on ’giant colonic diverticula’. Results: A total of 135 patients were identified, presenting with a total of 155 GCD [1–98]. With a complication rate of 28% and an operative mortality of 5%, GCD seems to have a high clinical significance. Radiological examination of choice seems to be plain abdominal X-ray and CT examination, barium enema carries the risk of perforation of the diverticulum, and should not be performed. Conclusions: There are different therapeutic options, in our opinion diverticulectomy alone is not the treatment of choice. Because of the possibility of recurrence and oncological reasons, colectomy seems to be the best treatment. The creation of a protecting colostomy depends on other operative findings.


  • Can laboratory investigations help us to decide when to discontinue larval therapy?

    by P. Steenvoorde, G.N. Jukema

    Objective: This study investigated retrospectively whether three laboratory investigations — testing for leucocyte levels, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) — can be used to guide the decision of when to discontinue larval therapy. Method: Between 1999 and 2002 we administered larval therapy to 16 inpatients. In all cases the decision to discontinue therapy was a clinical one made by the surgeon who headed the trauma department. We retrospectively analysed laboratory investigations, testing for leucocyte levels, CRP and ESR, on the first and last days of therapy to ascertain if the results could have guided this decision. Results: The median leucocyte count on the first day of larval therapy was 10.5 (x 10e9/L) compared with 8.4 (x 10e9/L) on the last day (Friedman test: p<0.05). CRP and ESR showed a non-significant tendency towards lower values. Conclusion: Although the methodological limitations of this open-label non-comparative cohort study preclude a definite conclusion, we believe that laboratory investigations, particularly leucocyte count, can guide the decision of when to discontinue larval therapy. However, this objective parameter cannot replace clinical judgement. Declaration of interest: None.